New Zealand markets closed

Oramed Pharmaceuticals Inc. (ORMP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.2400+0.0100 (+0.45%)
At close: 04:00PM EDT
2.1900 -0.05 (-2.23%)
After hours: 05:20PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate0.010-0.01-0.33
Low estimate-0.02-0.04-0.1-0.36
High estimate0.040.040.08-0.3
Year ago EPS-0.03-0.080.14-0.01
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2221
Avg. Estimate250k250k750k4M
Low estimateN/AN/AN/A4M
High estimate500k500k1.5M4M
Year ago sales674kN/A1.34M750k
Sales growth (year/est)-62.90%N/A-44.00%433.30%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.1-0.08-0.120.02
Actual EPS-0.03-0.080.330.04
Difference0.0700.450.02
Surprise %70.00%0.00%375.00%100.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate0.010-0.01-0.33
7 days ago0.010-0.01-0.33
30 days ago-0.02-0.04-0.25-0.36
60 days ago-0.02-0.03-0.26-1.08
90 days ago-0.02-0.03-0.26-1.08
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesORMPIndustrySector(s)S&P 500
Current qtr.133.30%N/AN/AN/A
Next qtr.100.00%N/AN/AN/A
Current year-107.10%N/AN/AN/A
Next year-3,200.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A